Categorizing accident sequences in the external radiotherapy for risk analysis
Jonghyun Kim
Radiat Oncol J. 2013;31(2):88-96. Published online 2013 Jun 30 DOI: https://doi.org/10.3857/roj.2013.31.2.88
|
Citations to this article as recorded by
Process failure mode and effects analysis for external beam radiotherapy: Introducing a literature-based template and a novel action priority
Dominik Kornek, Christoph Bert
Zeitschrift für Medizinische Physik.2024;[Epub] CrossRef Natural Polymeric Nanobiocomposites for Anti-Cancer Drug Delivery Therapeutics: A Recent Update
Arijit Mondal, Amit Nayak, Prithviraj Chakraborty, Sabyasachi Banerjee, Bankim Nandy
Pharmaceutics.2023; 15(8): 2064. CrossRef Rapid transitions in the standard of care for chronic lymphocytic leukemia (CLL)
Erlene K. Seymour
Oncotarget.2019; 10(26): 2484. CrossRef How I treat rituximab refractory patients with WM
Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Efstathios Kastritis, Meletios Athanasios Dimopoulos
Oncotarget.2018; 9(96): 36824. CrossRef Ibrutinib for rituximab-refractory Waldenström macro-globulinemia
Maria Gavriatopoulou, Efstathios Kastritis, Meletios Athanasios Dimopoulos
Oncotarget.2018; 9(16): 12536. CrossRef Analysis of setup error at rectal cancer radiotherapy technique
Jeong-Ho Kim, Seok-Hwan Bae, Ki-Jin Kim, Se-Jong Yu, Jee-Yoon Kim
Journal of the Korea Academia-Industrial cooperation Society.2013; 14(12): 6346. CrossRef
|